Related Experiment Video
Updated: May 28, 2026

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Critical limb ischemia
Paolo Gresele1, Chiara Busti, Tiziana Fierro
1Dipartimento di Medicina Interna, Sezione di Medicina Interna e Cardiovascolare, Università di Perugia, Via E. dal Pozzo, Perugia, Italy. grespa@unipg.it
Insights
Critical limb ischemia (CLI), the advanced stage of peripheral arterial disease, involves complex vascular changes causing severe pain and tissue loss. Management requires risk factor control, medical therapy, infection treatment, and multidisciplinary decisions on revascularization or amputation.
Area of Science:
- Vascular Medicine
- Cardiovascular Research
- Regenerative Medicine
Background:
- Critical limb ischemia (CLI) is the most severe manifestation of peripheral arterial disease, characterized by significant morbidity and mortality.
- Its pathophysiology involves complex macrovascular and microvascular circulatory dysfunction in the lower limbs, driven by atherosclerotic vascular remodeling, angiogenesis, and arteriogenesis.
- Common symptoms include rest pain, trophic skin changes, and tissue loss, necessitating prompt diagnosis and management.
Purpose of the Study:
- To provide a comprehensive overview of the pathophysiology, clinical manifestations, diagnostic methods, and therapeutic strategies for critical limb ischemia.
- To highlight the importance of risk factor control, medical management, and infection treatment in CLI patients.
- To discuss emerging therapeutic angiogenesis approaches and the complex decision-making process for revascularization versus amputation.
Main Methods:
- Review of current literature on critical limb ischemia pathophysiology and management.
- Synthesis of diagnostic criteria including physical examination, ankle-brachial index, duplex-ultrasound, and angiography.
- Evaluation of medical therapies, surgical interventions, and novel regenerative approaches.
Main Results:
- CLI results from advanced atherosclerotic disease affecting lower limb circulation.
- Diagnosis relies on clinical presentation and non-invasive/invasive vascular imaging.
- Effective management involves risk factor modification, antiplatelet therapy, infection control, and consideration of revascularization or amputation.
Conclusions:
- Critical limb ischemia management is complex, requiring a multidisciplinary approach.
- Risk factor control and timely intervention are crucial for improving outcomes.
- Further research, particularly phase II and III trials for therapeutic angiogenesis, is needed to advance treatment options.
Abstract:
Critical limb ischemia (CLI) represents the most advanced clinical stage of peripheral arterial disease. It is usually caused by obstructive atherosclerotic arterial disease and is associated with very high morbidity and mortality. The pathophysiology of CLI is a complex and chronic process affecting the macrovascular and microvascular circulation of the muscle and non-muscle tissues of the lower limbs. In particular, the atherosclerosis-related vascular remodelling, angiogenesis and arteriogenesis are central phenomena in the process. The most common clinical manifestations of CLI are limb pain at rest, with or without trophic skin changes or tissue loss. Diagnosis of CLI is based on physical examination, ankle-brachial index measurement, duplex-ultrasound and angiography; transcutaneous oxygen may also help. Risk factor control is recommended for all patients with CLI. Individuals with minimal or no skin breakdown or in whom comorbid conditions avoid revascularization can be treated with medical therapy (antiplatelet agents, intravenous prostanoids, rheologic agents). Treatment of infection is mandatory to decrease the metabolic demands that hamper wound healing. Therapeutic angiogenesis has been pursued with several approaches ranging from gene therapy to the use of bone marrow-derived progenitor cells, but further phase II and III trials are needed. Finally, the evaluation of the risk, benefit and optimal timing of revascularization lesions or the decision about amputation and its extension is a complex decision that requires a multidisciplinary approach.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care